<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><description>赛柏蓝（Mic366）,中国医药行业专业的资讯信息分享互动平台，致力于及时、准确、有用！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 02 May 2021 23:24:19 +0800</pubDate><image><url>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</url><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>大批药企，销售费用降了</title><link>https://mp.weixin.qq.com/s/50olUPd3zn4FWXVXys7htw</link><description></description><content:encoded><![CDATA[大批药企，销售费用降了]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>官方表扬，这些药企被点名（附名单）</title><link>https://mp.weixin.qq.com/s/m9xu_uXyg4mClMO6lQjeQQ</link><description></description><content:encoded><![CDATA[官方表扬，这些药企被点名（附名单）]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>2021年，这类医药人紧缺</title><link>https://mp.weixin.qq.com/s/O5fDUYoZijuiUIsnfipydA</link><description></description><content:encoded><![CDATA[2021年，这类医药人紧缺]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>这场医药峰会，太火爆了！千人云集上海，议程给力</title><link>https://mp.weixin.qq.com/s/EonvUMW8T3Rxg8tfEkBhkw</link><description></description><content:encoded><![CDATA[这场医药峰会，太火爆了！千人云集上海，议程给力]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>新营销模式两个收益点，药企赚了</title><link>https://mp.weixin.qq.com/s/rM56idz1UuC04eljq3namw</link><description></description><content:encoded><![CDATA[新营销模式两个收益点，药企赚了]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>药企投入最少，回报最大，有好办法了</title><link>https://mp.weixin.qq.com/s/pmXcldfWNBm5XfYkj8UL2g</link><description></description><content:encoded><![CDATA[药企投入最少，回报最大，有好办法了]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>医药营销，也有一条龙服务</title><link>https://mp.weixin.qq.com/s/wVRxte0OHnFR2m0ur4CIJw</link><description></description><content:encoded><![CDATA[医药营销，也有一条龙服务]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>特医食品不占药占比，在医院处方销售！</title><link>https://mp.weixin.qq.com/s/_Z1jnqsJ8iJdgLvBjFHYXw</link><description></description><content:encoded><![CDATA[特医食品不占药占比，在医院处方销售！]]></content:encoded><pubDate>Sun, 02 May 2021 18:05:32 +0800</pubDate></item><item><title>知名药企，总经理离职</title><link>https://mp.weixin.qq.com/s/7LpG5SV41P03cNXZObLHYw</link><description></description><content:encoded><![CDATA[知名药企，总经理离职]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>二甲双胍，又发现多个新作用</title><link>https://mp.weixin.qq.com/s/0aWuukngAjalebSwLVcPQg</link><description></description><content:encoded><![CDATA[二甲双胍，又发现多个新作用]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>今起！第四批国采结果，这些省执行</title><link>https://mp.weixin.qq.com/s/dzB4eTttfuwVfUw-eHt-KA</link><description></description><content:encoded><![CDATA[今起！第四批国采结果，这些省执行]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>第五个适应症获批！恒瑞医药卡瑞利珠单抗再下一城</title><link>https://mp.weixin.qq.com/s/6ZzF77cVLsyxcWulMULeuw</link><description></description><content:encoded><![CDATA[第五个适应症获批！恒瑞医药卡瑞利珠单抗再下一城]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>国家药典委，发布160个中药配方颗粒标准</title><link>https://mp.weixin.qq.com/s/WkGfqbWKpTBCNa99pAvvdg</link><description></description><content:encoded><![CDATA[国家药典委，发布160个中药配方颗粒标准]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药械营销迎来大变革</title><link>https://mp.weixin.qq.com/s/r0fBXIMpuYxGJw0PHu1Nbw</link><description></description><content:encoded><![CDATA[药械营销迎来大变革]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药企新品上市， 市场部策划攻略</title><link>https://mp.weixin.qq.com/s/40d2L3VRvkdSPASp4V4OwA</link><description></description><content:encoded><![CDATA[药企新品上市， 市场部策划攻略]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>药企两大痛点，阿斯利康公开解决方案</title><link>https://mp.weixin.qq.com/s/DWkCQaldnffCT9AQa9tv1g</link><description></description><content:encoded><![CDATA[药企两大痛点，阿斯利康公开解决方案]]></content:encoded><pubDate>Sat, 01 May 2021 17:54:29 +0800</pubDate></item><item><title>刚刚！国家医保局公布国谈药品最新消息</title><link>https://mp.weixin.qq.com/s/ci6EK86OSOx_5KGky7QRIg</link><description></description><content:encoded><![CDATA[刚刚！国家医保局公布国谈药品最新消息]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>知名药企，裁撤整个部门</title><link>https://mp.weixin.qq.com/s/vcHeKcJUO2xX-IJreLj_1Q</link><description></description><content:encoded><![CDATA[知名药企，裁撤整个部门]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>奥司他韦竞品，正式上市</title><link>https://mp.weixin.qq.com/s/Ncyh031CEcZoUUy64Mxz7Q</link><description></description><content:encoded><![CDATA[奥司他韦竞品，正式上市]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item><item><title>9个大品种，新一轮带量采购来了（附名单）</title><link>https://mp.weixin.qq.com/s/WcVpqtnJbmv2neqkGGA6fQ</link><description></description><content:encoded><![CDATA[9个大品种，新一轮带量采购来了（附名单）]]></content:encoded><pubDate>Fri, 30 Apr 2021 16:50:14 +0800</pubDate></item></channel></rss>